<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04048655</url>
  </required_header>
  <id_info>
    <org_study_id>R19095M</org_study_id>
    <nct_id>NCT04048655</nct_id>
  </id_info>
  <brief_title>Reversal of Neuromuscular Blockade During the General Anaesthesia</brief_title>
  <official_title>Reversal of Neuromuscular Blockade During the General Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are individual reports indicating that after the reversal of nondepolarizing
      neuromuscular blockade with neostigmine, some patients starts to relax spontaneously again
      after the tof ratio has already recovered to the safe level (&gt;90%).

      The mechanism behind this in not well understood, and the incidence of the phenomenon is
      unclear. In this study the investigators try to determine the incidence of the aforementioned
      postrecovery relaxation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are individual reports indicating that after the reversal of nondepolarizing
      neuromuscular blockade with neostigmine, some patients start to relax spontaneously again
      after the tof ratio has already recovered to the safe level (90%). The mechanism behind this
      in not well understood and the incidence of the phenomenon is unclear.

      The aim of this study is to monitor the reversal of rocuronium induced neuromuscular blockade
      with neostigmine. The neuromuscular blockade is monitored with train of four stimulations
      using electromyography. After the reversal agent is given and train of four ratio has
      recovered to the level of 90%, the neuromuscular blockade is monitored another 30min to see
      if tof ratio starts to spontaneously fall again under the 90%. If aforementioned postrecovery
      relaxation happens, the investigators are able to calculate the incidence of the phenomenon.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group with same study protocol to asses the incidence of postrecovery relaxation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postrecovery relaxation</measure>
    <time_frame>30 minutes</time_frame>
    <description>Number of patients (if any) with postrecovery relaxation divided by a number of all patients</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Single arm and everyone gets the same treatment according the protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine, Combinations</intervention_name>
    <description>All patients have neostigmine induced recovery of neuromuscular block.</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective surgery requiring general anaesthesia

          -  Surgery is assumed to last more than 45 minutes

          -  Body mass index less than 35kg/ m²

        Exclusion Criteria:

          -  Disease of central nervous system

          -  Trauma of central nervous system

          -  Disease affecting peripheral nervous system

          -  Medication affecting peripheral nervous system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maija Kalliomäki, Docent</last_name>
    <role>Study Director</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jarno Salminen, Licenciate</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jarno Salminen, Licenciate</last_name>
    <phone>+358503480709</phone>
    <email>jarno.o.salminen@tuni.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maija Kalliomäki, Docent</last_name>
    <phone>+358331161169424</phone>
    <email>maija-liisa.kalliomaki@pshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33520</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2019</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neuromuscular blockade</keyword>
  <keyword>neostigmine</keyword>
  <keyword>muscle relaxation</keyword>
  <keyword>train of four</keyword>
  <keyword>rocuronium</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

